NCT00292422View on ClinicalTrials.gov

Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Rheumatoid Arthritis
Interventions
DRUG

BG9924

Trial Locations (10)

19152

The Arthritis Group, Philadelphia

48910

Fiechtner Research Inc., Lansing

63141

Arthritis Consultants Inc., St Louis

15-337

Centrum Medyczne SpecjalistycznyGabinet Lekarski, Bialystok

82-300

Oddzial Reumatologii Wojewodzki Szpital, Elblag

20-022

Osrodek Badan Klinicznych, Lublin

87-100

"Prakyta Lekarza Rodzinnego Nasz Lekarz", Torun

02-637

Klinika Chorob Tkanki Lacznej-Instytut Reumatologiczny, Warsaw

Klinika Reumatologii-Instytut Reumatologiczny, Warsaw

02-777

Centrum Leczenia Chorob Cywilizacyjnych, Warsaw

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT00292422 - Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter